FRANK WEINHOLT: Open Payments
NPI 1326126442 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 93 payments from 10 companies in 2025. Trend: 2023 $1,729 · 2024 $2,172 · 2025 $2,029
Food & beverage: $2,000Education: $30
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 48 | $468 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $351 |
| Axsome Therapeutics, Inc. | 2 | $238 |
| Vanda Pharmaceuticals Inc. | 8 | $234 |
| E.R. Squibb & Sons, L.L.C. | 8 | $201 |
| Janssen Pharmaceuticals, Inc | 5 | $200 |
| Otsuka America Pharmaceutical, Inc. | 3 | $154 |
| Alkermes, Inc. | 2 | $123 |
| Lundbeck LLC | 2 | $46 |
| Alpha Cognition USA, Inc. | 1 | $14 |
Products named: NUPLAZID, CAPLYTA, Auvelity, FANAPT, COBENFY, REXULTI, INVEGA SUSTENNA, LYBALVI.
Industry payments across LA — which companies pay providers there.
